In vivo sensitivity test of Chloroquin on Plasmodium falciparum : A Study at Pituruh Sub District, Purworejo
Abstract
This study show that 45,6% P. falciparum was resistant to chloroquine, consisted of RI early recrudescence (16.22%), RI delayed recrudescence (8.11%), RII (16.22%), RIII (5.41%).
Key word: invivo test, P. falciparum, chloroquine
Full Text:
UntitledReferences
Anonim, 2001, Profil Kesehatan Kabupaten Purworejo tahun 2000, Dinas Kesehatan, Purworejo.
Anonim, 1993a. Malaria Pengobatan. Jakarta.
Goldsmith, R.S., 1994, Antiprotozoa in Katzung, B.G (ed) : Basic and Clinical Pharmacology, Appleton and Lange Division of Prentice Hall, California.
Hess, F.I., Iannuzi, A.,Leafasia, J., Cawdaly, D., Nothduafrt, H.D., Vansonenburg, F., Loschert, Rieckman, K.H., 1996. Risk factors of Chloroquine Resistance in Plasmodium falciparum Malaria. Acta trop. J. 61 (4). 293-306
Tambajong E.H., 2000, Patobiologi Malaria, Harijanto, P.N (ed) : Malaria : Epidemiologi, Patogenesis,Manifestasi Klinis dan Penanganan, 1st edition, EGC, Indonesia
Tjitra, E. Gunawan, S., Laihad., F., Marwoto, h., Sulaksono, S., Arjoso., Richie, T.L., Manurung, N.,1997, Evaluation of anti malaria Drugs in Indonesia 1981-1995. Buletin Penelitian Kesehatan. 25 (1) 1997 : 27-58
Tjokrosonto, S., 1990, Masalah resistensi terhadap Obat malaria di Indonesia, Lembaga Penelitian Universitas Gadjah Mada Departemen Pendidikan dan Kebudayaan, Yogyakarta.
WHO, 1993, Implementation of The Global Malaria Control Strategy. Geneva. WHO Technical Report Series. 839.
DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp81-88
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:
View My Stats